31403947|t|Predictors for Late Post-Intracerebral Hemorrhage Dementia in Patients with Probable Cerebral Amyloid Angiopathy.
31403947|a|BACKGROUND AND OBJECTIVE: Cerebral amyloid angiopathy (CAA) accounts for the majority of lobar intracerebral hemorrhage (ICH); however, the risk factors for dementia conversion after ICH occurrence in CAA patients are unknown, especially in the long-term period after ICH. Therefore, we aimed to unravel the predictors for late post-ICH dementia (6 months after ICH event) in probable CAA patients. METHODS: From a large consecutive MRI prospective cohort of spontaneous ICH (2006-2017), we identified probable CAA patients (modified Boston criteria) without dementia 6 months post-ICH. Cognitive outcome during follow-up was determined based on the information from standardized clinical visit notes. We used Cox regression analysis to investigate the association between baseline demographic characteristics, past medical history, MRI biomarkers, and late post-ICH dementia conversion (dementia occurred after 6 months). RESULTS: Among 97 non-demented lobar ICH patients with probable CAA, 25 patients (25.8%) developed dementia during a median follow-up time of 2.5 years (IQR 1.5-3.8 years). Pre-existing mild cognitive impairment, increased white matter hyperintensities (WMH) burden, the presence of disseminated cortical superficial siderosis (cSS), and higher total small vessel disease score for CAA were all independent predictors for late dementia conversion. CONCLUSION: In probable CAA patients presenting with lobar ICH, high WMH burden and presence of disseminated cSS are useful neuroimaging biomarkers for dementia risk stratification. These findings have implications for clinical practice and future trial design.
31403947	25	58	Intracerebral Hemorrhage Dementia	Disease	MESH:D002543
31403947	62	70	Patients	Species	9606
31403947	85	112	Cerebral Amyloid Angiopathy	Disease	MESH:D016657
31403947	140	167	Cerebral amyloid angiopathy	Disease	MESH:D016657
31403947	169	172	CAA	Disease	MESH:D016657
31403947	209	233	intracerebral hemorrhage	Disease	MESH:D002543
31403947	235	238	ICH	Disease	MESH:D002543
31403947	271	279	dementia	Disease	MESH:D003704
31403947	297	300	ICH	Disease	MESH:D002543
31403947	315	318	CAA	Disease	MESH:D016657
31403947	319	327	patients	Species	9606
31403947	382	385	ICH	Disease	MESH:D002543
31403947	447	450	ICH	Disease	MESH:D002543
31403947	451	459	dementia	Disease	MESH:D003704
31403947	476	479	ICH	Disease	MESH:D002543
31403947	499	502	CAA	Disease	MESH:D016657
31403947	503	511	patients	Species	9606
31403947	585	588	ICH	Disease	MESH:D002543
31403947	625	628	CAA	Disease	MESH:D016657
31403947	629	637	patients	Species	9606
31403947	673	681	dementia	Disease	MESH:D003704
31403947	696	699	ICH	Disease	MESH:D002543
31403947	977	980	ICH	Disease	MESH:D002543
31403947	981	989	dementia	Disease	MESH:D003704
31403947	1002	1010	dementia	Disease	MESH:D003704
31403947	1074	1077	ICH	Disease	MESH:D002543
31403947	1078	1086	patients	Species	9606
31403947	1101	1104	CAA	Disease	MESH:D016657
31403947	1109	1117	patients	Species	9606
31403947	1136	1144	dementia	Disease	MESH:D003704
31403947	1228	1248	cognitive impairment	Disease	MESH:D003072
31403947	1260	1289	white matter hyperintensities	Disease	MESH:D056784
31403947	1291	1294	WMH	Disease	MESH:D056784
31403947	1342	1363	superficial siderosis	Disease	MESH:D012806
31403947	1365	1368	cSS	Disease	MESH:D012806
31403947	1388	1408	small vessel disease	Disease	MESH:D059345
31403947	1419	1422	CAA	Disease	MESH:D016657
31403947	1464	1472	dementia	Disease	MESH:D003704
31403947	1509	1512	CAA	Disease	MESH:D016657
31403947	1513	1521	patients	Species	9606
31403947	1544	1547	ICH	Disease	MESH:D002543
31403947	1554	1557	WMH	Disease	MESH:D056784
31403947	1594	1597	cSS	Disease	MESH:D012806
31403947	1637	1645	dementia	Disease	MESH:D003704

